Literature DB >> 12204787

Cervical mucus granulocyte macrophage colony stimulating factor and interleukin-2 soluble receptor in women using copper intrauterine contraceptive devices.

Amal Shobokshi1, Mohamed Shaarawy.   

Abstract

This study was undertaken to investigate the role of cytokines in intrauterine contraception. Cervical mucus samples were obtained from 20 women with proven fertility 7, 14, 30, and 120 days after insertion of copper-T380 intrauterine devices (IUDs) for the determination of interleukin-2 (IL-2) soluble receptor (IL-2SR) and granulocyte macrophage colony stimulating factor (GM-CSF) concentrations. Both levels of IL-2SR and GM-CSF were significantly elevated after insertion of copper-releasing IUDs. This elevation remained significant through 6 months post-insertion. The mean-fold rise of GM-CSF compared to pre-insertion mean values amounted to 12.4, 11.8, 2.1, and 1.5 at 7, 14, 30, and 120 days post-insertion, respectively. The corresponding values for IL-2SR were 10.4, 8.8, 2.6, and 2.5, respectively. These results demonstrate enhanced local cytokines production in IUD users indicating local inflammatory reaction in the endometrium. This inflammatory reaction together with the cytotoxic effects of these cytokines may produce an environment which adversely affect embryo pre-implantation. This may explain the antifertility effect of copper IUDs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204787     DOI: 10.1016/s0010-7824(02)00331-1

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  4 in total

Review 1.  Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.

Authors:  Janet P Hapgood; Charu Kaushic; Zdenek Hel
Journal:  Endocr Rev       Date:  2018-02-01       Impact factor: 19.871

2.  The Effect of Contraception on Genital Cytokines in Women Randomized to Copper Intrauterine Device, Depot Medroxyprogesterone Acetate, or Levonorgestrel Implant.

Authors:  Ramla F Tanko; Rubina Bunjun; Smritee Dabee; Shameem Z Jaumdally; Maricianah Onono; Gonasagrie Nair; Thesla Palanee-Phillips; Rushil Harryparsad; Anna Ursula Happel; Hoyam Gamieldien; Yamkela Qumbelo; Musalula Sinkala; Caitlin W Scoville; Kate Heller; Jared M Baeten; Steven E Bosinger; Adam Burgener; Renee Heffron; Heather B Jaspan; Jo Ann S Passmore
Journal:  J Infect Dis       Date:  2022-09-13       Impact factor: 7.759

3.  Cervico-vaginal inflammatory cytokine alterations after intrauterine contraceptive device insertion: A pilot study.

Authors:  Priya Sharma; Kamnoosh Shahabi; Rachel Spitzer; Michele Farrugia; Rupert Kaul; Mark Yudin
Journal:  PLoS One       Date:  2018-12-04       Impact factor: 3.240

4.  Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out.

Authors:  Janet P Hapgood
Journal:  AIDS Res Hum Retroviruses       Date:  2020-01-22       Impact factor: 2.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.